A Model for Predicting the Duration of Viral Shedding in Patients Who Had Been Hospitalized with Mild COVID-19: A Single-Center Retrospective Study

References

• Diaz Badial P, Bothorel H, Kherad O, Dussoix P, Tallonneau Bory F, Ramlawi M. A new screening tool for SARS-CoV-2 infection based on self-reported patient clinical characteristics: the COV19-ID score. BMC Infect Dis. 2022;22(1):187. doi:10.1186/s12879-022-07164-1
   PubMedGoogle Scholar
• Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev. 2021;34(3):e00228–20. doi:10.1128/CMR.00228-20
   PubMed Web of Science ®Google Scholar
• Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141. doi:10.1038/s41392-022-00997-x
   PubMed Web of Science ®Google Scholar
• Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi:10.1136/bmj.m1328
   PubMed Web of Science ®Google Scholar
• Shankar S, Mohakuda SS, Kumar A, et al. Systematic review of predictive mathematical models of COVID-19 epidemic. Med J Armed Forces India. 2021;77(Suppl 2):S385–S392. doi:10.1016/j.mjafi.2021.05.005
   PubMedGoogle Scholar
• Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28–33. doi:10.1038/s41591-020-01202-8
   PubMed Web of Science ®Google Scholar
• Huang J, Xu Y, Wang B, et al. Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19. BMC Pulm Med. 2021;21(1):120. doi:10.1186/s12890-021-01487-6
   PubMed Web of Science ®Google Scholar
• Al Dhamen MA, Alhashim AF, Alqattan HH, Pottoo FH. COVID-19: an update on pathogenesis and treatment. Curr Pharm Des. 2021;27(32):3454–3461. doi:10.2174/1381612826666201222161312
   PubMed Web of Science ®Google Scholar
• Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):270. doi:10.1186/s12916-020-01726-3
   PubMed Web of Science ®Google Scholar
• Chen B, Geng P, Shen J, et al. Traditional Chinese medicine Jingyingubiao formula therapy improves the negative conversion rate of SARS-CoV2 in patients with mild COVID-19. Int J Biol Sci. 2022;18(15):5641–5652. doi:10.7150/ijbs.76699
   PubMed Web of Science ®Google Scholar
• Wang J, Bao A, Gu J, et al. A retrospective analysis of 12,400 SARS-CoV-2 RNA tests in patients with COVID-19 in Wuhan. Medicine. 2021;100(20):e25916. doi:10.1097/MD.0000000000025916
   PubMed Web of Science ®Google Scholar
• Ma C, Sun W, Tang T, et al. Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Yunnan, China, 2021. Vaccine. 2022;40(20):2869–2874. doi:10.1016/j.vaccine.2022.03.067
   PubMed Web of Science ®Google Scholar
• Han J, Shi LX, Xie Y, et al. Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration. Epidemiol Infect. 2020;148:e125. doi:10.1017/S0950268820001399
   PubMed Web of Science ®Google Scholar
• Li K, Zhang C, Qin L, et al. A nomogram prediction of length of hospital stay in patients with covid-19 pneumonia: a retrospective cohort study. Dis Markers. 2021;2021:5598824. doi:10.1155/2021/5598824
   PubMed Web of Science ®Google Scholar
• Liang W, Liang H, Ou L, et al., China Medical Treatment Expert Group for COVID-19. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089. doi:10.1001/jamainternmed.2020.2033
   PubMed Web of Science ®Google Scholar
• Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205. doi:10.1016/j.arr.2020.101205
   PubMed Web of Science ®Google Scholar
• Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–1839. doi:10.1016/j.jiph.2020.07.014
   PubMed Web of Science ®Google Scholar
• Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. 2020;12(13):12493–12503. doi:10.18632/aging.103579
   PubMedGoogle Scholar
• Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626–636. doi:10.1038/s41577-021-00592-1
   PubMed Web of Science ®Google Scholar
• Chiam T, Subedi K, Chen D, et al. Hospital length of stay among COVID-19-positive patients. J Clin Transl Res. 2021;7(3):377–385.
   PubMedGoogle Scholar
• Liu H, Shang X, Chen S, Li T, Zhang J. Cautions on the laboratory indicators of COVID-19 patients on and during admission. J Clin Lab Anal. 2021;35(5):e23767. doi:10.1002/jcla.23767
   PubMed Web of Science ®Google Scholar
• Salian VS, Wright JA, Vedell PT, et al. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol Pharm. 2021;18(3):754–771. doi:10.1021/acs.molpharmaceut.0c00608
   PubMed Web of Science ®Google Scholar
• Zheng B, Cai Y, Zeng F, et al. An interpretable model-based prediction of severity and crucial factors in patients with COVID-19. Biomed Res Int. 2021;2021:8840835. doi:10.1155/2021/8840835
   PubMed Web of Science ®Google Scholar
• Ma X, Li A, Jiao M, et al. Characteristic of 523 COVID-19 in Henan province and a death prediction model. Front Public Health. 2020;8:475. doi:10.3389/fpubh.2020.00475
   PubMed Web of Science ®Google Scholar
• Raza HA, Sen P, Bhatti OA, Gupta L. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatol Int. 2021;41(8):1375–1386. doi:10.1007/s00296-021-04873-9
   PubMed Web of Science ®Google Scholar
• Shu HM, He S, Sun Y, et al. Factors influencing viral clearance in mild COVID-19 and clinical characteristics of asymptomatic patients. Biomed Res Int. 2021;2021:5909612. doi:10.1155/2021/5909612
   PubMed Web of Science ®Google Scholar
• Samrah SM, Al-Mistarehi AH, Kewan T, et al. Viral clearance course of COVID-19 outbreaks. J Multidiscip Healthc. 2021;14:555–565. doi:10.2147/JMDH.S302891
   PubMed Web of Science ®Google Scholar
• Han C, Duan C, Zhang S, et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol. 2020;115(6):916–923. doi:10.14309/ajg.0000000000000664
   PubMed Web of Science ®Google Scholar
• Chen H, Tong Z, Ma Z, et al. Gastrointestinal bleeding, but not other gastrointestinal symptoms, is associated with worse outcomes in COVID-19 patients. Front Med. 2021;8:759152. doi:10.3389/fmed.2021.759152
   Web of Science ®Google Scholar
• Allali I, Bakri Y, Amzazi S, Ghazal H, Marquart ME. Gut-lung axis in COVID-19. Interdiscip Perspect Infect Dis. 2021;2021:6655380. doi:10.1155/2021/6655380
   PubMedGoogle Scholar
• Jaeken J, Wadman SK, Duran M, et al. Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr. 1988;148(2):126–131. doi:10.1007/BF00445919
   PubMed Web of Science ®Google Scholar
• Tjendra Y, Al Mana AF, Espejo AP, et al. Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med. 2020;144(12):1465–1474. doi:10.5858/arpa.2020-0471-SA
   PubMed Web of Science ®Google Scholar
• Anka AU, Tahir MI, Abubakar SD, et al. Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management. Scand J Immunol. 2021;93(4):e12998. doi:10.1111/sji.12998
   PubMed Web of Science ®Google Scholar
• Xie J, Ding C, Li J, et al. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. J Med Virol. 2020;92(10):2004–2010. doi:10.1002/jmv.25930
   PubMed Web of Science ®Google Scholar
• Masiá M, Telenti G, Fernández M, et al. SARS-CoV-2 seroconversion and viral clearance in patients hospitalized with COVID-19: viral load predicts antibody response. Open Forum Infect Dis. 2021;8(2):ofab005. doi:10.1093/ofid/ofab005
   PubMed Web of Science ®Google Scholar
• Xiao T, Wang Y, Yuan J, et al. Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers. Front Med. 2021;8:595773. doi:10.3389/fmed.2021.595773
   PubMed Web of Science ®Google Scholar
• Wisnewski AV, Campillo Luna J, Redlich CA, Ansari AA. Human IgG and IgA responses to COVID-19 mRNA vaccines. PLoS One. 2021;16(6):e0249499. doi:10.1371/journal.pone.0249499
   PubMed Web of Science ®Google Scholar
• Aranha C, Patel V, Bhor V, Gogoi D. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: an approach to reduce the isolation period for COVID-19 patients. J Med Virol. 2021;93(12):6794–6797. doi:10.1002/jmv.27206
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhou S, Wang G, et al. Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: a retrospective observational study. Front Public Health. 2022;10:1015811. doi:10.3389/fpubh.2022.1015811
   PubMed Web of Science ®Google Scholar
• Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–880. doi:10.1016/j.cell.2021.01.007
   PubMed Web of Science ®Google Scholar
• Jordan SC. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. Clin Exp Immunol. 2021;204(3):310–320. doi:10.1111/cei.13582
   PubMed Web of Science ®Google Scholar
• Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res. 2020;22(9):1653–1656. doi:10.1093/ntr/ntaa082
   PubMed Web of Science ®Google Scholar
• Ghazavi A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137:155323. doi:10.1016/j.cyto.2020.155323
   PubMed Web of Science ®Google Scholar
• Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428–455. doi:10.1111/all.14657
   PubMed Web of Science ®Google Scholar
• Huang L, Chen Z, Ni L, et al. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the inflammatory response and viral clearance in COVID-19 patients. Front Cardiovasc Med. 2021;8:710946. doi:10.3389/fcvm.2021.710946
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Gilligan MM, Huang S, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020;39(2):337–340. doi:10.1007/s10555-020-09889-4
   PubMed Web of Science ®Google Scholar
• Regidor PA, De La Rosa X, Santos FG, Rizo JM, Gracia Banzo R, Silva RS. Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids. Eur Rev Med Pharmacol Sci. 2021;25(21):6782–6796. doi:10.26355/eurrev_202111_27123
   PubMed Web of Science ®Google Scholar
• Chen X, Yan X, Sun K, et al. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022. Emerg Microbes Infect. 2022;11(1):2800–2807. doi:10.1080/22221751.2022.2128435
   PubMed Web of Science ®Google Scholar
• Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission. Rev Med Virol. 2022;32(5):e2381. doi:10.1002/rmv.2381
   PubMed Web of Science ®Google Scholar
• Mohandas S, Shete A, Kumar A, et al. Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the delta variant in Syrian hamsters. Front Microbiol. 2023;14:1183763. doi:10.3389/fmicb.2023.1183763
   PubMed Web of Science ®Google Scholar